ENDOLOGIX, INC. |
(Exact name of registrant as specified in its charter) |
Delaware | 000-28440 | 68-0328265 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
11 Studebaker, Irvine, CA | 92618 | |
(Address of principal executive offices) | (Zip Code) |
Registrant's telephone number, including area code: (949) 595-7200 |
N/A |
(Former name or former address, if changed since last report) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
• | it increases the maximum amount which Endologix can borrow under the Credit Agreement from $10,000,000 to $20,000,000 (subject to the calculation of the borrowing base, as amended by the Amendment); |
• | it increases the aggregate undrawn amount of outstanding letters of credit which Wells Fargo may issue from time to time under the Credit Agreement for the account of Endologix from $500,000 to $1,000,000; |
• | it increases the aggregate limit of the corporate credit cards which Wells Fargo may issue to Endologix from time to time under the Credit Agreement from $750,000 to $2,000,000 (which, if issued, reduce the aggregate borrowing limits under the Credit Agreement); |
• | it requires the subsidiaries of Endologix that own or hold assets equal to or greater than 10% of the total consolidated assets of Endologix and its subsidiaries to guarantee the payment of all indebtedness and other obligations of Endologix under the Credit Agreement; and |
• | it adds, amends or otherwise modifies certain financial covenants in the Credit Agreement. |
ENDOLOGIX, INC. | ||||
February 24, 2012 | /s/ Robert J. Krist | |||
Robert J. Krist | ||||
Chief Financial Officer |